Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
Recruiting · NCT06048484 · Registry updated 2026-02-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Recruiting | Phase 2 | 2026-02-27 | NCT06048484 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Arcus Biosciences, Inc. | 27 |
| Gulam Manji | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University Irving Medical Center | New York | United States | 234 |
| Medical College of Wisconsin | Milwaukee | United States | 483 |
| Northwell Health R.J. Zuckerberg Cancer Center | Lake Success | United States | 1 |
| UNC Hospitals, The University of North Carolina at Chapel Hill | Chapel Hill | United States | 5 |
| University of Pennsylvania, Abramson Cancer Center | Philadelphia | United States | 12 |